Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results

      Revenues and operating income grew 20.9% and 23.3%, respectively


      News provided by

      Zhongchao Inc.

      Apr 30, 2021, 09:00 ET

      Share this article

      Share this article


      SHANGHAI, April 30, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced its financial results for the fiscal year ended December 31, 2020.

      Key Financial Highlights for the Fiscal Year 2020 as compared to the Fiscal Year 2019



      For the Years Ended December 31,

      ($ millions, except per share data)

      2020


      2019


      % Change

      Revenues


      $17.99


      $14.88


      20.9%

      Gross profit


      $11.87


      $10.23


      16.1%

      Gross margin


      66.0%


      68.7%


      -2.7 pp

      Income from operations

      $4.49


      $3.64


      23.3%

      Operating margin


      25.0%


      24.5%


      0.5 pp

      Net income attributable to ordinary shareholders of
      Zhongchao

      $4.46


      $4.05


      10.2%

      Earnings per share


      $0.183


      $0.187


      -2.6%

      * pp: percentage points





      • Revenues increased by 20.9% to $17.99 million for the fiscal year 2020, primarily due to the increasing orders for assistance services for patient-aid projects.
      • Gross profit increased by 16.1% to $11.87 million while gross margin decreased by 2.7 percentage points to 66.0% for the fiscal year 2020.
      • Operating income increased by 23.3% to $4.49 million for the fiscal year 2020, primarily due to the increased gross profit and partially offset by the increased operating expenses.
      • Net income attributable to the Company's ordinary shareholders increased by 10.2% to $4.46 million for the fiscal year 2020, primarily driven by the increased income from operations and partially offset by the increased income tax expenses.
      • Earnings per share was $0.183 for the fiscal year 2020, compared to $0.187 for last year.

      Weiguang Yang, Chairman and Chief Executive Officer of Zhongchao, commented, "With revenues increasing by 20.9% to a record $17.99 million and operating income increasing by 23.3% to $4.49 million, our fiscal year 2020 financial results highlight continued strength in our businesses. Although our gross margin has a slight drawback, we expect to maintain a high-profit margin in the future for our reputation acknowledgment among leading pharmaceutical enterprises and non-for-profit organizations to design and produce high-quality professional content. In response to the outbreak of COVID-19, we, through our MDMOOC platform, have successfully developed and launched coronavirus curriculum with over 60 courses covering a wide range of medical specialties. In addition, our online courses increased 15% year-over-year in 2020. We are closely monitoring the fluid and uncertain situation of COVID-19, and we expect our revenues will continue to increase with the resume of work within China in the long-term."

      Financial Results for the Fiscal Year Ended December 31, 2020

      Revenues

      For the fiscal year 2020, revenues increased by $3.11 million, or 20.9%, to $17.99 million from $14.88 million for last year. The increase in revenues was primarily due to the increasing orders for assistance services for patient-aid projects.

      Cost of revenues

      Cost of revenue increased by $1.46 million, or 31.4%, to $6.12 million for the fiscal year 2020 from $4.66 million for last year. The increase in the cost of revenues was driven by the increases in professional service fees and outsourced labor cost as we employed increasing outsourced staff with an increase in patient-aid projects.  

      Gross profit

      Gross profit increased by $1.65 million, or 16.1%, to $11.87 million for the fiscal year 2020 from $10.23 million for last year.

      Gross margin decreased by 2.7 percentage points to 66.0% for the fiscal year 2020, compared to 68.7% for last year.  

      Operating expenses

      Selling and marketing expenses increased by $0.25 million, or 7.7%, to $3.44 million for the fiscal year 2020 from $3.20 million for last year. The increase in selling and marketing expenses was mainly attributable to the increase in advertising expenses to gain reputation in medical healthcare industry and the increase in salary and welfare to increase headcounts in selling and marketing department. As a percentage of total revenues, selling and marketing expenses was 19.1% for the fiscal year 2020, compared to 21.5% for last year.

      General and administrative expenses increased by $0.60 million, or 23.8%, to $3.12 million for the fiscal year 2020 from $2.52 million for last year. The increase in general and administrative expenses was mainly attributable to the increase in salary and welfare expenses as a result of combining effects of an increase of headcounts in supporting functions; the increase in professional expenses since the Company became listed since February 2020; and the increase in writing off doubtful accounts against accounts receivable in accordance with the bad debt policy. As a percentage of total revenues, general and administrative expenses was 17.4% for the fiscal year 2020, compared to 17.0% for last year.  

      Research and development expenses decreased by $0.05 million, or 5.5%, to $0.82 million for the fiscal year 2020 from $0.86 million for last year. As a percentage of total revenues, research and development expenses was 4.5% for the fiscal year 2020, compared to 5.8% for last year.  

      Total operating expenses increased by $0.80 million, or 12.1%, to $7.38 million for the fiscal year 2020 from $6.58 million for last year. The increase in operating expenses was mainly attributable to the increased selling and marketing expenses and general and administrative expenses and partially offset by the decreased research and development expenses.

      Operating income

      Income from operations increased by $0.85 million, or 23.3%, to $4.49 million for the fiscal year 2020 from $3.64 million for last year. The increase in income from operations was primarily driven by the increased gross profit and partially offset by the increased operating expenses.

      Operating margin increased by 0.5 percentage points to 25.0% for the fiscal year 2020 from 24.5% for last year.

      Interest and other income, net

      Interest income decreased by $0.07 million, or 30.5%, to $0.15 million for the fiscal year 2020 from $0.21 million for last year.

      Other income, primarily consisted of government subsidies, was $0.31 for the fiscal year 2020, compared to $0.53 million for last year.

      Income before income taxes

      Income before income taxes increased by $0.55 million, or 12.6%, to $4.94 million for the fiscal year 2020 from $4.39 million for last year. The increase in income before income taxes was primarily attributable to the increased income from operations and partially offset by the decreased interest and other income.

      Income tax expenses increased by $0.10 million, or 25.2%, to $0.49 million for the fiscal year 2020 from $0.39 million for last year.

      Net income and EPS

      Net income increased by $0.46 million, or 11.4%, to $4.46 million for the fiscal year 2020 from $4.00 million for last year. The increase in net income was primarily due to the increased income from operations and partially offset by the increased income tax expenses.

      Net margin decreased by 2.1 percentage points to 24.8% for the fiscal year 2020 from 26.9% for last year.

      After deducting for non-controlling interests, net income attributable to the Company's shareholders increased by $0.41 million, or 10.2%, to $4.46 million for the fiscal year 2020 from $4.05 million for last year.

      Basic and diluted earnings per share was $0.183 for the fiscal year 2020, compared to $0.187 for last year. Weighted average number of shares outstanding was 24,425,637 for the fiscal year 2020, compared to 21,600,135 for last year.  

      Financial Condition

      As of December 31, 2020, the Company had cash, and cash equivalents of $15.07 million, compared to $7.83 million as of December 31, 2019. Accounts receivable were $10.32 million as of December 31, 2020, compared to $5.08 million as of December 31, 2019. Working capital was $26.61 million as of December 31, 2020, compared to $12.15 million as of December 31, 2019.

      Net cash used in operating activities was $1.04 million for the fiscal year 2020, compared to net cash provided by operating activities of $1.41 million for last year. Net cash used in investing activities was $4.09 million for the fiscal year 2020, compared to $0.20 million for last year. Net cash provided by financing activities was $11.50 million for the fiscal year 2020, compared to net cash used in financing activities of $1.19 million for last year. 

      Recent Business Highlights

      • In March 2021, renewing the contract with China Association for Health Promotion and Education and GlaxoSmithKline (China) Investment Limited to continue the medical education program "Pulmonary Arterial Hypertension Online Course – Connections with Famous Hospitals" in 2021.
      • In January 2021, co-sponsoring the National Annual Conference for Standardized Liver Cancer Diagnosis and Treatment with China Association of Health Promotion and Education and Chinese Society of Liver Cancer.
      • In November 2020, expanding the scope of cooperation with Takeda Pharmaceutical in China to provide a broad range of services in medical editing, document collation, and medical training and education.

      About Zhongchao Inc.

      Incorporated in 2012 with headquarter offices in Shanghai and Beijing, China, Zhongchao Inc. is an online provider of healthcare information, professional training and educational services to healthcare professionals under its "MDMOOC" platform (www.mdmooc.org) and to the public under its "Sunshine Health Forums" platform (www.ygjkclass.com) in China. The Company also offers patient management services under its "Zhongxun" platform (www.zhongxun.online). More information about the Company can be found at its investor relations website at http://izcmd.com.

      Safe Harbor Statement

      This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following:  the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training and educational services market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

      For more information, please contact:

      At the Company:
      Pei Xu, CFO
      Email: [email protected] 
      Phone: +86 21-3220-5987

      Investor Relations:
      Sherry Zheng 
      Weitian Group LLC
      Email: [email protected]
      Phone: +1 718-213-7386

      ZHONGCHAO INC.

      CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

      (Expressed in U.S. dollar, except for the number of shares)




      For the Years Ended
      December 31,




      2020



      2019



      2018


      Revenues


      $

      17,989,788



      $

      14,882,763



      $

      12,865,870


      Cost of revenues



      (6,117,640)




      (4,655,827)




      (4,456,353)


      Gross Profit



      11,872,148




      10,226,936




      8,409,517















      Operating Expenses













      Selling and marketing expenses



      (3,441,941)




      (3,196,469)




      (2,261,258)


      General and administrative expenses



      (3,124,301)




      (2,524,003)




      (1,425,663)


      Research and development expenses



      (816,553)




      (864,320)




      (1,447,949)


      Total Operating Expenses



      (7,382,795)




      (6,584,792)




      (5,134,870)















      Income from Operations



      4,489,353




      3,642,144




      3,274,647















      Interest income, net



      146,965




      211,479




      191,609


      Other income, net



      305,566




      534,020




      37,364


      Income Before Income Taxes



      4,941,884




      4,387,643




      3,503,620















      Income tax expenses



      (484,787)




      (387,144)




      (502,131)















      Net Income



      4,457,097




      4,000,499




      3,001,489















      Net loss attributable to noncontrolling interests



      1,283




      46,171




      17,834















      Net Income Attributable to Zhongchao Inc.'s shareholders


      $

      4,458,380



      $

      4,046,670



      $

      3,019,323















      Other Comprehensive Income (Loss)













      Foreign currency translation adjustment



      1,259,984




      (173,604)




      (379,520)


      Comprehensive Income



      5,717,081




      3,826,895




      2,621,969















      Total comprehensive loss attributable to noncontrolling interests



      1,283




      46,171




      17,834


      Total comprehensive income attributable to Zhongchao Inc.'s
      shareholders


      $

      5,718,364



      $

      3,873,066



      $

      2,639,803















      Weighted average number of ordinary share outstanding













      Basic and Diluted



      24,425,637




      21,600,135




      20,764,245















      Earnings per share













      Basic and Diluted


      $

      0.183



      $

      0.187



      $

      0.145


      ZHONGCHAO INC.

      CONSOLIDATED BALANCE SHEETS

      (Expressed in U.S. dollar, except for the number of shares)




      December 31,
      2020



      December 31,
      2019


      ASSETS







      Current Assets







      Cash and cash equivalents


      $

      15,072,947



      $

      7,832,552


      Short-term investments



      2,032,928




      -


      Accounts receivable



      10,321,837




      5,078,419


      Prepayments



      554,298




      325,496


      Due from a related party



      -




      14,364


      Other current assets



      1,613,408




      1,258,040


      Total Current Assets



      29,595,418




      14,508,871











      Investment in a limited partnership



      1,258,787




      -


      Property and equipment, net



      1,997,761




      1,889,973


      Deposit for property



      700,884




      -


      Prepayments for lease of land



      367,588




      366,409


      Intangible assets, net



      34,973




      37,323


      Right of use assets



      65,137




      245,982


      Deferred tax assets



      795,547




      688,994


      Total Assets


      $

      34,816,095



      $

      17,737,552











      LIABILITIES AND EQUITY









      Current Liabilities









      Accounts payable


      $

      408,426



      $

      117,064


      Advances from customers



      6,760




      73,961


      Deferred government grants, current portion



      -




      323,192


      Income tax payable



      1,523,175




      897,892


      Operating lease liabilities, current portion



      62,160




      210,219


      Accrued expenses and other liabilities



      981,433




      735,334


      Total Current Liabilities



      2,981,954




      2,357,662











      Operating lease liabilities, noncurrent portion



      -




      41,363


      Total Liabilities



      2,981,954




      2,399,025











      Commitments and Contingencies


















      Equity









      Class A Ordinary Share (par value $0.0001 per share, 450,000,000 shares
          authorized; 19,435,423 and 16,102,420 shares issued and outstanding at
          December 31, 2020 and 2019, respectively)



      1,944




      1,610


      Class B Ordinary Share (par value $0.0001 per share, 50,000,000 shares authorized;
          5,497,715 and 5,497,715 shares issued and outstanding at December 31, 2020
          and 2019, respectively)



      550




      550


      Additional paid-in capital



      22,775,154




      12,044,855


      Statutory reserve



      801,502




      415,813


      Retained earnings



      7,339,778




      3,267,087


      Accumulated other comprehensive income (loss)



      915,213




      (344,771)


      Total Zhongchao Inc.'s Shareholders' Equity



      31,834,141




      15,385,144











      Noncontrolling interests



      -




      (46,617)


      Total Equity



      31,834,141




      15,338,527


      Total Liabilities and Equity


      $

      34,816,095



      $

      17,737,552


      ZHONGCHAO INC.

      CONSOLIDATED STATEMENTS OF CASH FLOWS

      (Expressed in U.S. dollar, except for the number of shares) 




      For the Years Ended
      December 31,




      2020



      2019



      2018


      Cash Flows from Operating Activities:













      Net income


      $

      4,457,097



      $

      4,000,499



      $

      3,001,489


      Adjustments to reconcile net income to net cash (used in) provided
          by operating activities:













      Write off against accounts receivable



      336,367




      -




      -


      Depreciation and amortization expenses



      202,325




      102,905




      38,699


      Amortization of right of use assets



      222,353




      159,259




      -


      Recognition (reversal) of share-based compensation expenses



      168,350




      159,984




      (14,483)


      Deferred tax (benefits) expenses



      (58,424)




      (318,087)




      60,975


      Equity investment loss



      25,622




      -




      -


      Changes in fair value of short-term investments



      10,331




      -




      -


      Changes in operating assets and liabilities:













      Accounts receivable



      (5,486,914)




      (3,134,065)




      (792,031)


      Prepayments



      (197,402)




      231,894




      (583,613)


      Other current assets



      (1,143,200)




      119,523




      (659,145)


      Accounts payable



      260,350




      94,461




      (548,507)


      Advances from customers



      6,398




      (476,261)




      (125,872)


      Income tax payable



      535,981




      618,120




      296,904


      Accrued expenses and other liabilities



      179,738




      408,725




      85,954


      Lease liabilities



      (230,819)




      (153,616)




      -


      Deferred government grants



      (325,992)




      (405,321)




      552,277


      Net Cash (Used in) Provided by Operating Activities



      (1,037,839)




      1,408,020




      1,312,647















      Cash Flows from Investing Activities:













      Purchases of property and equipment



      (160,602)




      (1,312,941)




      (668,067)


      Payments of deposits for property purchase



      (688,267)




      -




      -


      Payment for land use rights



      -




      -




      (418,520)


      Investments in short-term investments



      (2,043,259)




      (2,460,879)




      (2,920,260)


      Investment in a limited partnership



      (1,217,039)




      -




      -


      Release from short-term investments



      -




      3,618,940




      3,502,799


      Buy out of a non-controlling interests



      -




      (33,718)




      -


      Loan repayment from (provided to) a related party



      14,489




      (14,476)




      -


      Net Cash Used in Investing Activities



      (4,094,678)




      (203,074)




      (504,048)















      Cash Flows from Financing Activities:













      Proceeds from issuance of common stocks in connection with
          initial public offering, net of offering cost



      11,886,363




      -




      -


      Payment of expenses relating to initial public offerings



      (388,709)




      (468,328)




      -


      Capital contribution from shareholders



      -




      -




      3,580,260


      Proceeds from bank borrowings



      -




      -




      756,544


      Repayment of bank borrowings



      -




      (723,788)




      -


      Net Cash Provided by (Used in) Financing Activities



      11,497,654




      (1,192,116)




      4,336,804















      Effect of exchange rate changes on cash and cash equivalents



      875,258




      (98,953)




      (205,243)















      Net increase (decrease) in cash and cash equivalents



      7,240,395




      (86,123)




      4,940,160


      Cash and cash equivalents at beginning of year



      7,832,552




      7,918,675




      2,978,515


      Cash and cash equivalents at end of year


      $

      15,072,947



      $

      7,832,552



      $

      7,918,675















      Supplemental Cash Flow Information













      Cash paid for interest expense


      $

      -



      $

      30,312



      $

      5,840


      Cash paid for income tax


      $

      2,642



      $

      87,111



      $

      144,252















      Noncash investing activities













      Right of use assets obtained in exchange for operating lease
          obligations


      $

      37,919



      $

      419,362



      $

      -


      SOURCE Zhongchao Inc.

      Modal title

      Also from this source

      Zhongchao Inc. Announces 1-for-2 Share Consolidation

      Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer ...

      Zhongchao Inc. Announces $5.0 Million Registered Direct Offering

      Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain investors...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Earnings

      Earnings

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.